GeurtsMMETalsmaJBrouwersJRBJde GierJJ. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol2012;74(1):16–33.
3.
HatahEBraundRTordoffJDuffullSB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol2014;77(1):102–15.
4.
HollandRLenaghanEHarveyIet al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ2005;330(7486): 293.
5.
HenrichNTsaoNGastonguayLLyndLMarraCA. BC Medication Management Project: perspectives of pharmacists, patients and physicians. Can Pharm J (Ott)2015;148(2): 90–100.
6.
RileyK. Enhanced medication management services in the community: a win-win proposal from an economic, clinical and humanistic perspective. Can Pharm J (Ott)2013;146(3): 162–8.
7.
KolhatkarAChengLChanFKIHarrisonMLawMR. The impact of medication reviews by community pharmacists. J Am Pharm Assoc2016;56(5):513–20.
8.
JamesonJVanNoordGVanderwoudK. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract1995;41(5):469–72.
9.
ChumneyECRobinsonLC. The effects of pharmacist interventions on patients with polypharmacy. Pharm Pract2006;4(3):103–9.
10.
HollandRDesboroughJGoodyerLHallSWrightDLokeYK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol2008;65(3):303–16.
11.
TrygstadTKChristensenDGarmiseJSullivanRWegnerS. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative. J Manag Care Pharm2005;11(7):575–83.
12.
ZermanskyAGPettyDRRaynorDKFreemantleNVailALoweCJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ2001; 323(7325):1340–3.
13.
AltavelaJLJonesMKRitterM. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system. J Manag Care Pharm2008; 14(9):831–43.
14.
MasonJDColleyCA. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial. Ann Pharmacother1993;27(5):555–9.
15.
MooreJMShartleDFaudskarLMatlinOSBrennanTA. Impact of a patient-centered pharmacy program and intervention in a high-risk group. J Manag Care Pharm2013; 19(3):228–36.
16.
KolhatkarAChengLChanFKIHarrisonMLawMR. The impact of medication reviews by community pharmacists. J Am Pharm Assoc2016;56(5):513–520.e1.
17.
KrskaJCromartyJAArrisFet al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing2001;30(3):205–11.
18.
LobasNHLepinskiPWAbramowitzPW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm1992;49(7):1681–8.
19.
SellorsJKaczorowskiJSellorsCet al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ Can Med Assoc J2003;169(1):17–22.
20.
ZarowitzBJStebelskyLAMumaBKRomainTMPetersonEL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy2005;25(11):1636–45.
21.
GaltKA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy1998;18(5): 1103–11.
22.
JamesonJPVanNoordGR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother2001;35(7–8):835–40.
JorgensonDJLandryEJLysakKJ. A mixed methods evaluation of a patient care clinic located within a pharmacy school. Int J Clin Pharm2016;38(4):924–30.
25.
American Geriatrics Society, 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc2015;63(11):2227–46.